Skip to main content
Erschienen in: Journal of Bone and Mineral Metabolism 3/2016

17.06.2015 | Original Article

Differences in vertebral, tibial, and iliac cancellous bone metabolism in ovariectomized rats

verfasst von: Aya Takakura, Ryoko Takao-Kawabata, Yukihiro Isogai, Makoto Kajiwara, Hisashi Murayama, Sadakazu Ejiri, Toshinori Ishizuya

Erschienen in: Journal of Bone and Mineral Metabolism | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Bone histomorphometry is usually performed on the iliac bone in humans and the tibia or vertebrae in rats. Bone metabolism differences among skeletal sites may be problematic when translating experimental results from rats to humans, but data on such differences in rats are lacking. Therefore, we examined the differences in bone structure and metabolism among skeletal sites using the lumbar vertebra (LV), tibia, and iliac bone obtained from ovariectomized or sham-operated rats preoperatively and at various times from 3 days to 26 weeks postoperatively. The trabeculae were thicker in the LV, where bone metabolism was less active than at other sites, and numerous fine trabeculae were observed in the tibia, where bone metabolism was more active. The iliac bone structure and metabolism were intermediate between those of the tibia and LV. Ovariectomy induced lower bone volume and higher bone metabolism in all skeletal sites, but the changes were greatest and occurred earliest in the tibia, followed by the iliac bone and then LV. Ovariectomy caused changes in bone metabolic markers, which occurred earlier than those in bone tissue. Activation frequency (Ac.f) increased after ovariectomy. At week 26 in ovariectomized rats, Ac.f was highest in the tibia (3.13 N/year) but similar between iliac bone (0.87 N/year) and LV (1.39 N/year). Ac.f is reportedly 0.3–0.4 N/year in the iliac bone of postmenopausal women, suggesting that bone turnover in rats is several times higher than in humans. The reference values reported here are useful for translating experimental results from rats to humans.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Food and Drug Administration Division of Metabolic and Endocrine Drug Products (1994) Guideline for preclinical and clinical evaluation of agents used in the prevention or treatment of postmenopausal osteoporosis Food and Drug Administration Division of Metabolic and Endocrine Drug Products (1994) Guideline for preclinical and clinical evaluation of agents used in the prevention or treatment of postmenopausal osteoporosis
2.
Zurück zum Zitat World Health Organization (1998) Guidelines for preclinical and clinical trials in osteoporosis World Health Organization (1998) Guidelines for preclinical and clinical trials in osteoporosis
3.
Zurück zum Zitat Ministry of Health Labour and Welfare of Japan Evaluation and Licensing Division of the Pharmaceutical and Food Safety Bureau (1999) Guideline on clinical evaluation of drugs to treat osteoporosis. PFSB/ELD Notification No. 742 Ministry of Health Labour and Welfare of Japan Evaluation and Licensing Division of the Pharmaceutical and Food Safety Bureau (1999) Guideline on clinical evaluation of drugs to treat osteoporosis. PFSB/ELD Notification No. 742
4.
Zurück zum Zitat Smith SY, Recker RR, Hannan M, Muller R, Bauss F (2003) Intermittent intravenous administration of the bisphosphonate ibandronate prevents bone loss and maintains bone strength and quality in ovariectomized cynomolgus monkeys. Bone 32:45–55CrossRefPubMed Smith SY, Recker RR, Hannan M, Muller R, Bauss F (2003) Intermittent intravenous administration of the bisphosphonate ibandronate prevents bone loss and maintains bone strength and quality in ovariectomized cynomolgus monkeys. Bone 32:45–55CrossRefPubMed
5.
Zurück zum Zitat Wronski TJ, Cintron M, Dann LM (1988) Temporal relationship between bone loss and increased bone turnover in ovariectomized rats. Calcif Tissue Int 43:179–183CrossRefPubMed Wronski TJ, Cintron M, Dann LM (1988) Temporal relationship between bone loss and increased bone turnover in ovariectomized rats. Calcif Tissue Int 43:179–183CrossRefPubMed
6.
Zurück zum Zitat Wronski TJ, Dann LM, Horner SL (1989) Time course of vertebral osteopenia in ovariectomized rats. Bone 10:295–301CrossRefPubMed Wronski TJ, Dann LM, Horner SL (1989) Time course of vertebral osteopenia in ovariectomized rats. Bone 10:295–301CrossRefPubMed
7.
Zurück zum Zitat Hodsman AB, Kiesel M, Fraher LJ, Watson PH, Stitt LW (1998) Comparison of the response of pelvic and proximal tibial cancellous bone in rat to ovariectomy with estrogen replacement. Bone 23:267–274CrossRefPubMed Hodsman AB, Kiesel M, Fraher LJ, Watson PH, Stitt LW (1998) Comparison of the response of pelvic and proximal tibial cancellous bone in rat to ovariectomy with estrogen replacement. Bone 23:267–274CrossRefPubMed
8.
Zurück zum Zitat Tanizawa T, Yamaguchi A, Uchiyama Y, Miyaura C, Ikeda T, Ejiri S, Nagal Y, Yamato H, Murayama H, Sato M, Nakamura T (2000) Reduction in bone formation and elevated bone resorption in ovariectomized rats with special reference to acute inflammation. Bone 26:43–53CrossRefPubMed Tanizawa T, Yamaguchi A, Uchiyama Y, Miyaura C, Ikeda T, Ejiri S, Nagal Y, Yamato H, Murayama H, Sato M, Nakamura T (2000) Reduction in bone formation and elevated bone resorption in ovariectomized rats with special reference to acute inflammation. Bone 26:43–53CrossRefPubMed
9.
Zurück zum Zitat Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595–610CrossRefPubMed Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595–610CrossRefPubMed
10.
Zurück zum Zitat Dempster DW, Compston JE, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR, Parfitt AM (2013) Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 28:2–17CrossRefPubMedPubMedCentral Dempster DW, Compston JE, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR, Parfitt AM (2013) Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 28:2–17CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Li XJ, Jee WS, Ke HZ, Mori S, Akamine T (1991) Age-related changes of cancellous and cortical bone histomorphometry in female Sprague-Dawley rats. Cells Mater 1:25–35 Li XJ, Jee WS, Ke HZ, Mori S, Akamine T (1991) Age-related changes of cancellous and cortical bone histomorphometry in female Sprague-Dawley rats. Cells Mater 1:25–35
12.
Zurück zum Zitat Kimmel DB, Recker RR, Gallagher JC, Vaswani AS, Aloia JF (1990) A comparison of iliac bone histomorphometric data in post-menopausal osteoporotic and normal subjects. Bone Miner 11:217–235CrossRefPubMed Kimmel DB, Recker RR, Gallagher JC, Vaswani AS, Aloia JF (1990) A comparison of iliac bone histomorphometric data in post-menopausal osteoporotic and normal subjects. Bone Miner 11:217–235CrossRefPubMed
13.
Zurück zum Zitat Ma YF, Ke HZ, Jee WS (1994) Prostaglandin E2 adds bone to a cancellous bone site with a closed growth plate and low bone turnover in ovariectomized rats. Bone 15:137–146CrossRefPubMed Ma YF, Ke HZ, Jee WS (1994) Prostaglandin E2 adds bone to a cancellous bone site with a closed growth plate and low bone turnover in ovariectomized rats. Bone 15:137–146CrossRefPubMed
14.
Zurück zum Zitat Harris ST, Eriksen EF, Davidson M, Ettinger MP, Moffett AH Jr, Baylink DJ, Crusan CE, Chines AA (2001) Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women. J Clin Endocrinol Metab 86:1890–1897PubMed Harris ST, Eriksen EF, Davidson M, Ettinger MP, Moffett AH Jr, Baylink DJ, Crusan CE, Chines AA (2001) Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women. J Clin Endocrinol Metab 86:1890–1897PubMed
15.
Zurück zum Zitat Weinstein RS, Parfitt AM, Marcus R, Greenwald M, Crans G, Muchmore DB (2003) Effects of raloxifene, hormone replacement therapy, and placebo on bone turnover in postmenopausal women. Osteoporos Int 14:814–822CrossRefPubMed Weinstein RS, Parfitt AM, Marcus R, Greenwald M, Crans G, Muchmore DB (2003) Effects of raloxifene, hormone replacement therapy, and placebo on bone turnover in postmenopausal women. Osteoporos Int 14:814–822CrossRefPubMed
16.
Zurück zum Zitat Miki T, Nakatsuka K, Naka H, Masaki H, Imanishi Y, Ito M, Inaba M, Morii H, Nishizawa Y (2004) Effect and safety of intermittent weekly administration of human parathyroid hormone 1–34 in patients with primary osteoporosis evaluated by histomorphometry and microstructural analysis of iliac trabecular bone before and after 1 year of treatment. J Bone Miner Metab 22:569–576CrossRefPubMed Miki T, Nakatsuka K, Naka H, Masaki H, Imanishi Y, Ito M, Inaba M, Morii H, Nishizawa Y (2004) Effect and safety of intermittent weekly administration of human parathyroid hormone 1–34 in patients with primary osteoporosis evaluated by histomorphometry and microstructural analysis of iliac trabecular bone before and after 1 year of treatment. J Bone Miner Metab 22:569–576CrossRefPubMed
17.
Zurück zum Zitat Yamazaki I, Yamaguchi H (1989) Characteristics of an ovariectomized osteopenic rat model. J Bone Miner Res 4:13–22CrossRefPubMed Yamazaki I, Yamaguchi H (1989) Characteristics of an ovariectomized osteopenic rat model. J Bone Miner Res 4:13–22CrossRefPubMed
18.
Zurück zum Zitat Fukuda S, Iida H (1991) Age and sex-related changes of bone metabolism in normal rats and the effects in ovariectomized and orchidectomized rats at different ages. J Jpn Soc Bone Morphom 1:89–94 Fukuda S, Iida H (1991) Age and sex-related changes of bone metabolism in normal rats and the effects in ovariectomized and orchidectomized rats at different ages. J Jpn Soc Bone Morphom 1:89–94
19.
Zurück zum Zitat Elsubeihi ES, Bellows CG, Jia Y, Heersche JN (2007) Ovariectomy of 12-month-old rats: effects on osteoprogenitor numbers in bone cell populations isolated from femur and on histomorphometric parameters of bone turnover in corresponding tibia. Cell Tissue Res 330:515–526CrossRefPubMed Elsubeihi ES, Bellows CG, Jia Y, Heersche JN (2007) Ovariectomy of 12-month-old rats: effects on osteoprogenitor numbers in bone cell populations isolated from femur and on histomorphometric parameters of bone turnover in corresponding tibia. Cell Tissue Res 330:515–526CrossRefPubMed
Metadaten
Titel
Differences in vertebral, tibial, and iliac cancellous bone metabolism in ovariectomized rats
verfasst von
Aya Takakura
Ryoko Takao-Kawabata
Yukihiro Isogai
Makoto Kajiwara
Hisashi Murayama
Sadakazu Ejiri
Toshinori Ishizuya
Publikationsdatum
17.06.2015
Verlag
Springer Japan
Erschienen in
Journal of Bone and Mineral Metabolism / Ausgabe 3/2016
Print ISSN: 0914-8779
Elektronische ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-015-0678-y

Weitere Artikel der Ausgabe 3/2016

Journal of Bone and Mineral Metabolism 3/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.